Switch to:
GuruFocus has detected 5 Warning Signs with Teva Pharmaceutical Industries Ltd $TEVA.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Cash Flow from Others
$1,745 Mil (TTM As of Mar. 2017)

Teva Pharmaceutical Industries Ltd's cash flow from others for the three months ended in Mar. 2017 was $-11 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2017 was $1,745 Mil.


Definition

Teva Pharmaceutical Industries Ltd Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2017 was 670 (Jun. 2016 ) + -409 (Sep. 2016 ) + 1495 (Dec. 2016 ) + -11 (Mar. 2017 ) = $1,745 Mil.


Related Terms

Cash Flow from Operations


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Cash Flow from Others 831,9311021441121,1486904181,3162,032

Teva Pharmaceutical Industries Ltd Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
Cash Flow from Others 151179192792153276670-4091,495-11
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK